PM
49
2
EMN
56
-2
IP
28
-3
COP
47
3
UNM
65
-7
ECL
57
3
M
58
5
FITB
75
2
STZ
42
-2
HCA
64
5
SWKS
55
2
MHK
43
-2
CME
45
3
MU
75
4
NKE
28
-12
HRL
23
-12
CAG
41
-5
AIG
77
2
EMR
64
5
PRU
62
2
PM
49
2
EMN
56
-2
IP
28
-3
COP
47
3
UNM
65
-7
ECL
57
3
M
58
5
FITB
75
2
STZ
42
-2
HCA
64
5
SWKS
55
2
MHK
43
-2
CME
45
3
MU
75
4
NKE
28
-12
HRL
23
-12
CAG
41
-5
AIG
77
2
EMR
64
5
PRU
62
2
Financhill
Back

Intellia Therapeutics, Inc. Vs. Ascendis Pharma A/S Industry Stock Comparison

Sell
19

NTLA
Intellia Therapeutics, Inc.

Last Price:
$9.69
Seasonality Move:
-6.88%
Sell
40

ASND
Ascendis Pharma A/S

Last Price:
$209.19
Seasonality Move:
19.56%
Sell
19
Intellia Therapeutics, Inc. (NTLA) is a Sell

Is Intellia Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Intellia Therapeutics, Inc. [NTLA] share price is $9.23. The Score for NTLA is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
  • NTLA is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
40
Ascendis Pharma A/S (ASND) is a Sell

Is Ascendis Pharma A/S a Buy, Sell or Hold?

  • The current Ascendis Pharma A/S [ASND] share price is $199.99. The Score for ASND is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
  • ASND is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

NTLA Stock Price Chart

What is Intellia Therapeutics, Inc.'s stock price today?

ASND Stock Price Chart

What is Ascendis Pharma A/S's stock price today?

  • The Ascendis Pharma A/S share price today is $199.99
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ASND is experiencing slight buying pressure.

NTLA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.74 Sell
Relative Strength Index (14 RSI): 43.35 Sell
Chaikin Money Flow: 205899 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (8.36 - 9.34) Buy
Bollinger Bands (100): (8.08 - 18.94) Sell

ASND Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.34 Sell
Relative Strength Index (14 RSI): 44.76 Sell
Chaikin Money Flow: 14533 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (202.09 - 213.85) Sell
Bollinger Bands (100): (192.48 - 209.22) Sell

NTLA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 9.14 Buy
20-day SMA: 8.97 Buy
50-day SMA: 13.31 Sell
200-day SMA: 11.33 Sell
8-day EMA: 9.09 Buy
20-day EMA: 9.44 Sell
50-day EMA: 11.41 Sell
200-day EMA: 12.87 Sell

ASND Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 207.47 Sell
20-day SMA: 206.98 Sell
50-day SMA: 205.78 Sell
200-day SMA: 182.32 Buy
8-day EMA: 205.13 Sell
20-day EMA: 206.26 Sell
50-day EMA: 204.64 Sell
200-day EMA: 184.52 Buy

Intellia Therapeutics, Inc. Earnings Growth & NTLA Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.31 per share, and an increase next year of $0.38 per share.

Ascendis Pharma A/S Earnings Growth & ASND Earnings Dates

  • Analysts estimate an earnings increase this quarter of $1.33 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.00 per share, and an increase next year of $7.73 per share.

Intellia Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ascendis Pharma A/S Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):